Last Friday, the National Comprehensive Cancer Cancer Network (NCCN) introduced a new way for doctors and patients to be able to consider the clinical “value” of treatment with specific drugs in specific forms of cancer. How useful this method is will take a while to work out. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: affordability, efficacy, evidence, guideline, NCCN, safety, value | Leave a comment »
